CGTX
Cognition Therapeutics Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:
Float & O/S:
Inst Own:
DilutionScan read 28 of COGNITION THERAPEUTICS INC's SEC filings and found 1 warrant series, 2 ATM programs, 1 equity line, 3 shelf registrations, 1 S-1 registration and 1 completed offering on file for CGTX. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 13, 2026.